source · application/json
source_6dce41e77ed14ae3
sha256 cc99adc962987d9dbe1e462207c68b8014a21ba1e352fd9e310c9fe7e7f447dc
by researka:v2 · 2026-08-15 17:04:25.109728+04:00
{"contradictions": ["The human randomized controlled trial (RCT) landscape for telomere-focused interventions is characterized by diverse study designs, populations, and endpoints, leading to a mixed and sometimes contradictory evidence base. Many trials are mechanistic or biomarker-focused, assessing TL change as a primary or secondary endpoint without clinical outcomes. This diversity of trial contexts and populations makes it difficult to synthesize a unified narrative about the efficacy of interventions aimed at modifying telomere length.", "This synthesis aims to contribute by systematically examining the tensions between mechanistic plausibility and clinical evidence within the telomere measurement and intervention literature. A central challenge is the separation of clinical from mechanistic evidence, as findings from different outcome domains cannot be directly compared. The review will therefore weight the evidence by separating these layers: mapping the landscape of human RCTs that have directly measured telomere length change, examining the observational associations with longevity and specific diseases, and evaluating the mechanistic studies that inform biological plausibility. The goal is to identify where the evidence is consistent, where it is contradictory, and where the most significant gaps remain, particularly concerning the functional consequences of modifying telomere length and the boundary conditions for any potential clinical benefit.", "| Telomere Measurement Methods / Contextual Adjacent Evidence | n=25; claims=319 | positive=1, negative=2, null=2, mixed=1, unclear=19 (n=25) | 17 direct; 5 indirect; 3 review | limited corpus depth in this outcome class |", "| Telomere Measurement Methods / Cardiometabolic | n=4; claims=30 | positive=0, negative=0, null=0, mixed=0, unclear=4 (n=4) | 3 direct; 1 review | limited corpus depth in this outcome class |", "| Telomere Measurement Methods / Immune and Inflammation | n=4; claims=72 | positive=0, negative=0, null=2, mixed=0, unclear=2 (n=4) | 2 direct; 1 indirect; 1 review | limited corpus depth in this outcome class |", "| Telomere Measurement Methods / Longevity | n=2; claims=44 | positive=1, negative=0, null=0, mixed=0, unclear=1 (n=2) | 1 direct; 1 review | limited corpus depth in this outcome class |", "| Telomere Measurement Methods / Animal/Preclinical Context | n=1; claims=11 | positive=0, negative=0, null=0, mixed=0, unclear=1 (n=1) | 1 mechanistic | single-source slice; hypothesis-generating |", "| Telomere Measurement Methods / Deficiency Prevalence | n=1; claims=14 | positive=0, negative=0, null=0, mixed=0, unclear=1 (n=1) | 1 indirect | single-source slice; hypothesis-generating |", "| Telomere Measurement Methods / Frailty | n=1; claims=10 | positive=0, negative=0, null=0, mixed=0, unclear=1 (n=1) | 1 indirect | single-source slice; hypothesis-generating |", "| Telomere Measurement Methods / Mortality and Survival | n=1; claims=13 | positive=0, negative=0, null=0, mixed=0, unclear=1 (n=1) | 1 indirect | single-source slice; hypothesis-generating |", "| Telomere Measurement Methods / Muscle Function | n=1; claims=7 | positive=0, negative=0, null=0, mixed=0, unclear=1 (n=1) | 1 review | single-source slice; hypothesis-generating |", "Ribeiro 2021 [bundle:1] (Short-Term Aerobic Exercise Did Not Change Telomere Length While It Reduced Testosterone Levels and Obesity Indexes in; representative statistic p ≤ 0.001; source-level statistic reported; outcome=Contextual Adjacent Evidence; direction=unclear; directness=direct; tier=A1).", "Thesis:** Across 40 curated reference papers, the evidence base for Telomere shows a context-dependent profile. Positive signals appear in: longevity, Contextual Adjacent Evidence. Negative signals appear in: Contextual Adjacent Evidence. Null findings dominate: immune inflammation, Contextual Adjacent Evidence. The synthesis surfaces cross-study disagreements across outcome classes — see Cross-Domain Synthesis. The Telomere broad aging-related case as currently constituted is incomplete: mechanistic plausibility coexists with mixed or sparse human-RCT evidence, and the boundary conditions remain to be established. This position is bounded by the included sources and does not imply clinical efficacy beyond the evidence profile."], "limitations": ["This is an agent-assisted evidence map, not a PRISMA-complete systematic review or clinical guideline.", "It is not PROSPERO-registered and should not be read as medical advice.", "Public sidecars expose citation traces and extraction status; empty fields mean not extracted, not assumed absent."], "publication_id": "28e44ab0-b228-4dba-8e70-b25bbc6c7ac8", "screening": {"excluded": 0, "exclusion_reasons": ["No PRISMA full-text exclusion-stage filter was applied."], "flow": ["identified", "screened", "excluded_with_reasons", "included"], "identified": 40, "included": 40, "included_or_retained": 40, "screened": 40, "wording": "40 candidate receipts retained after source retrieval, deduplication, and topic filtering. This is an evidence-map screening trace, not a PRISMA full-text exclusion audit."}}
metadata
{
"researka_object_type": "publication_sidecar",
"researka_publication_id": "28e44ab0-b228-4dba-8e70-b25bbc6c7ac8",
"researka_submission_id": "cdc02f9b-5c5a-431c-bc2c-5052d42442e6",
"sidecar_name": "contradiction_map.json",
"sidecar_url": "https://api.researka.org/publications/28e44ab0-b228-4dba-8e70-b25bbc6c7ac8/sidecars/contradiction_map.json"
}